CRNX Financials
Crinetics Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$84.95
Market Cap
$2.76B
P/E Ratio
-23.0
EPS
$-4.71
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$1.04M
Gross Profit
-
Operating Income
-
Net Income
$-298.41M
EPS (Diluted)
$-3.69
Balance Sheet Highlights
Total Assets
$1.43B
Total Liabilities
$109.79M
Shareholders Equity
-
Cash & Equivalents
$264.55M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-225.97M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-99710.5%
ROE
-44.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CRNX revenue?
CRNX's most recent quarterly revenue was $1.04M. Annual revenue can be calculated by summing the four most recent quarters.
Is CRNX profitable?
CRNX reported a loss of $298.41M in the most recent quarter.
What is CRNX market cap?
CRNX has a market capitalization of $2.76B, making it a mid-cap stock.
Does CRNX have debt?
View CRNX's balance sheet for debt information.
What is CRNX cash flow?
Cash flow data is available in the full financial statements.